Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study
- PMID: 9745406
- DOI: 10.1210/jcem.83.9.5090
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study
Abstract
Estimates of the prevalence of the polycystic ovary syndrome (PCOS) in the general population have ranged from 2-20%. The vast majority of these reports have studied White populations in Europe, used limited definitions of the disorder, and/or used bias populations, such as those seeking medical care. To estimate the prevalence of this disorder in the United States and address these limitations, we prospectively determined the prevalence of PCOS in a reproductive-aged population of 369 consecutive women (174 White and 195 Black; aged 18-45 yr), examined at the time of their preemployment physical. Body measures were obtained, and body hair was quantified by a modified Ferriman-Gallwey (F-G) method. All exams were initially performed by 2 trained nurses, and any subject with an F-G score above 3 was reexamined by a physician, the same for all patients. Of the 369 women, 277 (75.1%) also agreed to complete a questionnaire and have additional blood drawn. Subjects were studied regardless of current estrogen/progestin hormonal use (28.5%). PCOS was defined as 1) oligoovulation, 2) clinical hyperandrogenism (i.e. hirsutism) and/or hyperandrogenemia, and 3) exclusion of other related disorders, such as hyperprolactinemia, thyroid abnormalities, and non-classic adrenal hyperplasia. Hirsutism was defined by a F-G score of 6 or more, and hyperandrogenemia was defined as a total or free testosterone, androstenedione, and/or dehydroepiandrosterone sulfate level above the 95th percentile of control values [i.e. all eumenorrheic women in the study, who had no hirsutism (F-G < or = 5) or acne and were receiving no hormonal therapy; n = 98]. Considering all 369 women studied, White and Black women had similar mean ages (29.4 +/- 7.1 and 31.1 +/- 7.8 yr, respectively), although White women had a lesser body mass than Black women (24.9 +/- 6.1 vs. 29.2 +/- 8.1 kg/m2, respectively; P < 0.001). Of these 7.6%, 4.6%, and 1.9% demonstrated a F-G score of 6 or more, 8 or 10, respectively, and there was no significant racial difference, with hirsutism prevalences of 8.0%, 2.8%, and 1.6% in Whites, and 7.1%, 6.1%, and 2.1% in Blacks, respectively. Of the 277 women consenting to a history and hormonal evaluation, 4.0% had PCOS as defined, 4.7% (6 of 129) of Whites and 3.4% (5 of 148) of Blacks. In conclusion, in our consecutive population of unselected women the prevalence of hirsutism varied from 2-8% depending on the chosen cut-off F-G score, with no significant difference between White and Black women. Using an F-G score of 6 or more as indicative of hirsutism, 3.4% of Blacks and 4.7% of Whites had PCOS as defined. These data suggest that PCOS may be one of most common reproductive endocrinological disorders of women.
Similar articles
-
The prevalence and features of the polycystic ovary syndrome in an unselected population.J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9. doi: 10.1210/jc.2003-032046. J Clin Endocrinol Metab. 2004. PMID: 15181052
-
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8. doi: 10.1210/jcem.85.7.6682. J Clin Endocrinol Metab. 2000. PMID: 10902790
-
Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States.J Clin Endocrinol Metab. 2023 Feb 15;108(3):706-712. doi: 10.1210/clinem/dgac515. J Clin Endocrinol Metab. 2023. PMID: 36218376 Free PMC article.
-
Androgen excess: Investigations and management.Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:98-118. doi: 10.1016/j.bpobgyn.2016.05.003. Epub 2016 May 19. Best Pract Res Clin Obstet Gynaecol. 2016. PMID: 27387253 Review.
-
Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.J Am Acad Dermatol. 2014 Nov;71(5):847.e1-847.e10; quiz 857-8. doi: 10.1016/j.jaad.2014.05.007. Epub 2014 Oct 15. J Am Acad Dermatol. 2014. PMID: 25437977 Review.
Cited by
-
Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome.J Endocrinol Invest. 2021 Mar;44(3):505-513. doi: 10.1007/s40618-020-01332-3. Epub 2020 Jun 15. J Endocrinol Invest. 2021. PMID: 32557272 Free PMC article.
-
A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS.Reprod Biol Endocrinol. 2023 Nov 23;21(1):111. doi: 10.1186/s12958-023-01159-6. Reprod Biol Endocrinol. 2023. PMID: 37996893 Free PMC article. Review.
-
Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia.Iran J Reprod Med. 2015 Feb;13(2):93-100. Iran J Reprod Med. 2015. PMID: 25999998 Free PMC article.
-
Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women.J Clin Endocrinol Metab. 2012 Aug;97(8):2836-43. doi: 10.1210/jc.2012-1259. Epub 2012 May 8. J Clin Endocrinol Metab. 2012. PMID: 22569241 Free PMC article. Clinical Trial.
-
Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):121-5. doi: 10.1136/jnnp.73.2.121. J Neurol Neurosurg Psychiatry. 2002. PMID: 12122167 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical